 | • レポートコード：D0GIR-00940 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、人工膵臓デバイスシステムの世界市場を広く調査・分析し、今後の市場展望をまとめております。人工膵臓デバイスシステムの種類別市場規模（スレッショルドサスペンドデバイスシステム、ノンスレッショルドサスペンドデバイスシステム（NTSDS）、コントロールトゥレンジシステム（CTRS）、コントロールトゥターゲットシステム（CTTS））、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Medtronic、Cellnovo、Tandem Diabetes Care、Johnson & Johnson、Bigfoot Biomedical、Insulet、Dose Safety、Beta Bionics、Roche、Dexcom、DreaMed Diabetes、Inreda Diabetic ・地域別グローバル市場分析 2015年-2020年 ・人工膵臓デバイスシステムの北米市場（アメリカ、カナダ、メキシコ） ・人工膵臓デバイスシステムのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・人工膵臓デバイスシステムのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・人工膵臓デバイスシステムの南米市場（ブラジル、アルゼンチン） ・人工膵臓デバイスシステムの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：スレッショルドサスペンドデバイスシステム、ノンスレッショルドサスペンドデバイスシステム（NTSDS）、コントロールトゥレンジシステム（CTRS）、コントロールトゥターゲットシステム（CTTS） ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Artificial Pancreas Devices System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.6% in the forecast period of 2020 to 2025 and will expected to reach USD 113.9 million by 2025, from USD 73 million in 2019.
The Artificial Pancreas Devices System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Artificial Pancreas Devices System market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Artificial Pancreas Devices System market has been segmented into:
Threshold Suspend Device System
Non-Threshold Suspend Device System (NTSDS)
Control to Range System (CTRS)
Control to Target System (CTTS)
By Application, Artificial Pancreas Devices System has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Artificial Pancreas Devices System market presented in the report. This section sheds light on the sales growth of different regional and country-level Artificial Pancreas Devices System markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Artificial Pancreas Devices System market.
The report offers in-depth assessment of the growth and other aspects of the Artificial Pancreas Devices System market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Artificial Pancreas Devices System Market Share Analysis
Artificial Pancreas Devices System competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Artificial Pancreas Devices System sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Artificial Pancreas Devices System sales, revenue and market share for each player covered in this report.
The major players covered in Artificial Pancreas Devices System are:
Medtronic
Cellnovo
Tandem Diabetes Care
Johnson & Johnson
Bigfoot Biomedical
Insulet
Dose Safety
Beta Bionics
Roche
Dexcom
DreaMed Diabetes
Inreda Diabetic
Table of Contents
1 Artificial Pancreas Devices System Market Overview
1.1 Product Overview and Scope of Artificial Pancreas Devices System
1.2 Classification of Artificial Pancreas Devices System by Type
1.2.1 Global Artificial Pancreas Devices System Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Artificial Pancreas Devices System Revenue Market Share by Type in 2019
1.2.3 Threshold Suspend Device System
1.2.4 Non-Threshold Suspend Device System (NTSDS)
1.2.5 Control to Range System (CTRS)
1.2.6 Control to Target System (CTTS)
1.3 Global Artificial Pancreas Devices System Market by Application
1.3.1 Overview: Global Artificial Pancreas Devices System Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Artificial Pancreas Devices System Market by Regions
1.4.1 Global Artificial Pancreas Devices System Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Artificial Pancreas Devices System (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Artificial Pancreas Devices System Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Artificial Pancreas Devices System Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Artificial Pancreas Devices System Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Artificial Pancreas Devices System Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Artificial Pancreas Devices System Status and Prospect (2015-2025)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cellnovo
2.2.1 Cellnovo Details
2.2.2 Cellnovo Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cellnovo SWOT Analysis
2.2.4 Cellnovo Product and Services
2.2.5 Cellnovo Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.3 Tandem Diabetes Care
2.3.1 Tandem Diabetes Care Details
2.3.2 Tandem Diabetes Care Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Tandem Diabetes Care SWOT Analysis
2.3.4 Tandem Diabetes Care Product and Services
2.3.5 Tandem Diabetes Care Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bigfoot Biomedical
2.5.1 Bigfoot Biomedical Details
2.5.2 Bigfoot Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bigfoot Biomedical SWOT Analysis
2.5.4 Bigfoot Biomedical Product and Services
2.5.5 Bigfoot Biomedical Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.6 Insulet
2.6.1 Insulet Details
2.6.2 Insulet Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Insulet SWOT Analysis
2.6.4 Insulet Product and Services
2.6.5 Insulet Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dose Safety
2.7.1 Dose Safety Details
2.7.2 Dose Safety Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Dose Safety SWOT Analysis
2.7.4 Dose Safety Product and Services
2.7.5 Dose Safety Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beta Bionics
2.8.1 Beta Bionics Details
2.8.2 Beta Bionics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beta Bionics SWOT Analysis
2.8.4 Beta Bionics Product and Services
2.8.5 Beta Bionics Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.10 Dexcom
2.10.1 Dexcom Details
2.10.2 Dexcom Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Dexcom SWOT Analysis
2.10.4 Dexcom Product and Services
2.10.5 Dexcom Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.11 DreaMed Diabetes
2.11.1 DreaMed Diabetes Details
2.11.2 DreaMed Diabetes Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 DreaMed Diabetes SWOT Analysis
2.11.4 DreaMed Diabetes Product and Services
2.11.5 DreaMed Diabetes Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
2.12 Inreda Diabetic
2.12.1 Inreda Diabetic Details
2.12.2 Inreda Diabetic Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Inreda Diabetic SWOT Analysis
2.12.4 Inreda Diabetic Product and Services
2.12.5 Inreda Diabetic Artificial Pancreas Devices System Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Artificial Pancreas Devices System Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Artificial Pancreas Devices System Players Market Share
3.2.2 Top 10 Artificial Pancreas Devices System Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Artificial Pancreas Devices System Revenue and Market Share by Regions
4.2 North America Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
4.3 Europe Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
4.5 South America Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
5 North America Artificial Pancreas Devices System Revenue by Countries
5.1 North America Artificial Pancreas Devices System Revenue by Countries (2015-2020)
5.2 USA Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
5.3 Canada Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
5.4 Mexico Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
6 Europe Artificial Pancreas Devices System Revenue by Countries
6.1 Europe Artificial Pancreas Devices System Revenue by Countries (2015-2020)
6.2 Germany Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
6.3 UK Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
6.4 France Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
6.5 Russia Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
6.6 Italy Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Artificial Pancreas Devices System Revenue by Countries
7.1 Asia-Pacific Artificial Pancreas Devices System Revenue by Countries (2015-2020)
7.2 China Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
7.3 Japan Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
7.4 Korea Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
7.5 India Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
8 South America Artificial Pancreas Devices System Revenue by Countries
8.1 South America Artificial Pancreas Devices System Revenue by Countries (2015-2020)
8.2 Brazil Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
8.3 Argentina Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Artificial Pancreas Devices System by Countries
9.1 Middle East & Africa Artificial Pancreas Devices System Revenue by Countries (2015-2020)
9.2 Saudi Arabia Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
9.3 UAE Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
9.4 Egypt Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
9.5 South Africa Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Artificial Pancreas Devices System Revenue and Market Share by Type (2015-2020)
10.2 Global Artificial Pancreas Devices System Market Forecast by Type (2019-2024)
10.3 Threshold Suspend Device System Revenue Growth Rate (2015-2025)
10.4 Non-Threshold Suspend Device System (NTSDS) Revenue Growth Rate (2015-2025)
10.5 Control to Range System (CTRS) Revenue Growth Rate (2015-2025)
10.6 Control to Target System (CTTS) Revenue Growth Rate (2015-2025)
11 Global Artificial Pancreas Devices System Market Segment by Application
11.1 Global Artificial Pancreas Devices System Revenue Market Share by Application (2015-2020)
11.2 Artificial Pancreas Devices System Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Artificial Pancreas Devices System Market Size Forecast (2021-2025)
12.1 Global Artificial Pancreas Devices System Market Size Forecast (2021-2025)
12.2 Global Artificial Pancreas Devices System Market Forecast by Regions (2021-2025)
12.3 North America Artificial Pancreas Devices System Revenue Market Forecast (2021-2025)
12.4 Europe Artificial Pancreas Devices System Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Artificial Pancreas Devices System Revenue Market Forecast (2021-2025)
12.6 South America Artificial Pancreas Devices System Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Artificial Pancreas Devices System Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Artificial Pancreas Devices System Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Artificial Pancreas Devices System by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Artificial Pancreas Devices System Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Artificial Pancreas Devices System Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Medtronic Corporate Information, Location and Competitors
Table 6. Medtronic Artificial Pancreas Devices System Major Business
Table 7. Medtronic Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 8. Medtronic SWOT Analysis
Table 9. Medtronic Artificial Pancreas Devices System Product and Solutions
Table 10. Medtronic Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Cellnovo Corporate Information, Location and Competitors
Table 12. Cellnovo Artificial Pancreas Devices System Major Business
Table 13. Cellnovo Artificial Pancreas Devices System Total Revenue (USD Million) (2018-2019)
Table 14. Cellnovo SWOT Analysis
Table 15. Cellnovo Artificial Pancreas Devices System Product and Solutions
Table 16. Cellnovo Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Tandem Diabetes Care Corporate Information, Location and Competitors
Table 18. Tandem Diabetes Care Artificial Pancreas Devices System Major Business
Table 19. Tandem Diabetes Care Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 20. Tandem Diabetes Care SWOT Analysis
Table 21. Tandem Diabetes Care Artificial Pancreas Devices System Product and Solutions
Table 22. Tandem Diabetes Care Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Johnson & Johnson Corporate Information, Location and Competitors
Table 24. Johnson & Johnson Artificial Pancreas Devices System Major Business
Table 25. Johnson & Johnson Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 26. Johnson & Johnson SWOT Analysis
Table 27. Johnson & Johnson Artificial Pancreas Devices System Product and Solutions
Table 28. Johnson & Johnson Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bigfoot Biomedical Corporate Information, Location and Competitors
Table 30. Bigfoot Biomedical Artificial Pancreas Devices System Major Business
Table 31. Bigfoot Biomedical Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 32. Bigfoot Biomedical SWOT Analysis
Table 33. Bigfoot Biomedical Artificial Pancreas Devices System Product and Solutions
Table 34. Bigfoot Biomedical Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Insulet Corporate Information, Location and Competitors
Table 36. Insulet Artificial Pancreas Devices System Major Business
Table 37. Insulet Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 38. Insulet SWOT Analysis
Table 39. Insulet Artificial Pancreas Devices System Product and Solutions
Table 40. Insulet Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Dose Safety Corporate Information, Location and Competitors
Table 42. Dose Safety Artificial Pancreas Devices System Major Business
Table 43. Dose Safety Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 44. Dose Safety SWOT Analysis
Table 45. Dose Safety Artificial Pancreas Devices System Product and Solutions
Table 46. Dose Safety Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Beta Bionics Corporate Information, Location and Competitors
Table 48. Beta Bionics Artificial Pancreas Devices System Major Business
Table 49. Beta Bionics Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 50. Beta Bionics SWOT Analysis
Table 51. Beta Bionics Artificial Pancreas Devices System Product and Solutions
Table 52. Beta Bionics Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Artificial Pancreas Devices System Major Business
Table 55. Roche Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Artificial Pancreas Devices System Product and Solutions
Table 58. Roche Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Dexcom Corporate Information, Location and Competitors
Table 60. Dexcom Artificial Pancreas Devices System Major Business
Table 61. Dexcom Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 62. Dexcom SWOT Analysis
Table 63. Dexcom Artificial Pancreas Devices System Product and Solutions
Table 64. Dexcom Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. DreaMed Diabetes Corporate Information, Location and Competitors
Table 66. DreaMed Diabetes Artificial Pancreas Devices System Major Business
Table 67. DreaMed Diabetes Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 68. DreaMed Diabetes SWOT Analysis
Table 69. DreaMed Diabetes Artificial Pancreas Devices System Product and Solutions
Table 70. DreaMed Diabetes Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Inreda Diabetic Corporate Information, Location and Competitors
Table 72. Inreda Diabetic Artificial Pancreas Devices System Major Business
Table 73. Inreda Diabetic Artificial Pancreas Devices System Total Revenue (USD Million) (2017-2018)
Table 74. Inreda Diabetic SWOT Analysis
Table 75. Inreda Diabetic Artificial Pancreas Devices System Product and Solutions
Table 76. Inreda Diabetic Artificial Pancreas Devices System Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Artificial Pancreas Devices System Revenue (Million USD) by Players (2015-2020)
Table 78. Global Artificial Pancreas Devices System Revenue Share by Players (2015-2020)
Table 79. Global Artificial Pancreas Devices System Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Artificial Pancreas Devices System Revenue Market Share by Regions (2015-2020)
Table 81. North America Artificial Pancreas Devices System Revenue by Countries (2015-2020)
Table 82. North America Artificial Pancreas Devices System Revenue Market Share by Countries (2015-2020)
Table 83. Europe Artificial Pancreas Devices System Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Artificial Pancreas Devices System Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Artificial Pancreas Devices System Revenue by Countries (2015-2020)
Table 86. South America Artificial Pancreas Devices System Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Artificial Pancreas Devices System Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Artificial Pancreas Devices System Revenue Market Share by Countries (2015-2020)
Table 89. Global Artificial Pancreas Devices System Revenue (Million USD) by Type (2015-2020)
Table 90. Global Artificial Pancreas Devices System Revenue Share by Type (2015-2020)
Table 91. Global Artificial Pancreas Devices System Revenue Forecast by Type (2021-2025)
Table 92. Global Artificial Pancreas Devices System Revenue by Application (2015-2020)
Table 93. Global Artificial Pancreas Devices System Revenue Share by Application (2015-2020)
Table 94. Global Artificial Pancreas Devices System Revenue Forecast by Application (2021-2025)
Table 95. Global Artificial Pancreas Devices System Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Artificial Pancreas Devices System Picture
Figure 2. Global Artificial Pancreas Devices System Revenue Market Share by Type in 2019
Figure 3. Threshold Suspend Device System Picture
Figure 4. Non-Threshold Suspend Device System (NTSDS) Picture
Figure 5. Control to Range System (CTRS) Picture
Figure 6. Control to Target System (CTTS) Picture
Figure 7. Artificial Pancreas Devices System Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Other Picture
Figure 11. Global Artificial Pancreas Devices System Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Artificial Pancreas Devices System Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Artificial Pancreas Devices System Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Artificial Pancreas Devices System Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Artificial Pancreas Devices System Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Artificial Pancreas Devices System Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Artificial Pancreas Devices System Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Artificial Pancreas Devices System Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Artificial Pancreas Devices System Revenue Market Share in 2019
Figure 20. Global Top 10 Players Artificial Pancreas Devices System Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Artificial Pancreas Devices System Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Artificial Pancreas Devices System Revenue Market Share by Regions (2015-2020)
Figure 24. Global Artificial Pancreas Devices System Revenue Market Share by Regions in 2018
Figure 25. North America Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 26. Europe Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 28. South America Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 30. North America Artificial Pancreas Devices System Revenue Market Share by Countries (2015-2020)
Figure 31. North America Artificial Pancreas Devices System Revenue Market Share by Countries in 2019
Figure 32. USA Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 33. Canada Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 35. Europe Artificial Pancreas Devices System Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Artificial Pancreas Devices System Revenue Market Share by Countries in 2019
Figure 37. Germany Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 38. UK Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 39. France Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 40. Russia Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 41. Italy Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Artificial Pancreas Devices System Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Artificial Pancreas Devices System Revenue Market Share by Countries in 2019
Figure 44. China Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 45. Japan Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 46. Korea Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 47. India Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 49. South America Artificial Pancreas Devices System Revenue Market Share by Countries (2015-2020)
Figure 50. South America Artificial Pancreas Devices System Revenue Market Share by Countries in 2019
Figure 51. Brazil Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Artificial Pancreas Devices System Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Artificial Pancreas Devices System Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 56. UAE Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Artificial Pancreas Devices System Revenue and Growth Rate (2015-2020)
Figure 59. Global Artificial Pancreas Devices System Revenue Share by Type (2015-2020)
Figure 60. Global Artificial Pancreas Devices System Revenue Share by Type in 2019
Figure 61. Global Artificial Pancreas Devices System Market Share Forecast by Type (2021-2025)
Figure 62. Global Threshold Suspend Device System Revenue Growth Rate (2015-2020)
Figure 63. Global Non-Threshold Suspend Device System (NTSDS) Revenue Growth Rate (2015-2020)
Figure 64. Global Control to Range System (CTRS) Revenue Growth Rate (2015-2020)
Figure 65. Global Control to Target System (CTTS) Revenue Growth Rate (2015-2020)
Figure 66. Global Artificial Pancreas Devices System Revenue Share by Application (2015-2020)
Figure 67. Global Artificial Pancreas Devices System Revenue Share by Application in 2019
Figure 68. Global Artificial Pancreas Devices System Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Artificial Pancreas Devices System Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Artificial Pancreas Devices System Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Artificial Pancreas Devices System Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Artificial Pancreas Devices System Revenue Market Forecast (2021-2025)
Figure 76. Europe Artificial Pancreas Devices System Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Artificial Pancreas Devices System Revenue Market Forecast (2021-2025)
Figure 78. South America Artificial Pancreas Devices System Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Artificial Pancreas Devices System Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
音声認識システムの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Voice Recognition System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.9% in the forecast period of 2020 to 2025 and will expected to reach USD 1789.8 million by 2025, from USD 1028.3 million in 2019. The Voice Reco…- 人工臓器・バイオニックインプラントの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Artificial Organs & Bionic Implants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.2% in the forecast period of 2020 to 2025 and will expected to reach USD 64070 million by 2025, from USD 50410 million in 2019. The Ar…
- 薬物密閉型移送装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Drugs Closed System Transfer Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- マイクロ流体デバイスシステムの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Microfluidic Device System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.4% in the forecast period of 2020 to 2025 and will expected to reach USD 7060.5 million by 2025, from USD 4428 million in 2019. The Microfluid…
- 肝生検システムの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Liver Biopsy System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Liver Biopsy System marke…